Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12619000956101
ACTRN12619000956101
Recruiting
未知

Reducing Morbidity and Mortality by Initiation of a novel In-Hospital Treatment for Patients with T2DM (REMIT-2-D).

Health Translation SA, South Australian Health and Medical Research institute0 sites198 target enrollmentJuly 8, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Health Translation SA, South Australian Health and Medical Research institute
Enrollment
198
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Health Translation SA, South Australian Health and Medical Research institute

Eligibility Criteria

Inclusion Criteria

  • •1\.Non\-Indigenous and Indigenous peoples of age 18 years and over.
  • •2\.Patients with Type 2 Diabetes Mellitus with an underlying cardiac condition admitted to hospital

Exclusion Criteria

  • •1\.Non\-Indigenous and Indigenous peoples under the age of 18 years.
  • •2\.Women who are pregnant.
  • •3\.Patients unable to give informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
REDUCING EARLY MORTALITY AND EARLY MORBIDITY BY EMPIRIC TUBERCULOSIS TREATMENT REGIMENS (REMEMBER)
PER-030-11El Instituto Nacional de Alergia y Enfermedades Infecciosas (NIAID) de los Estados Unidos,
Completed
Not Applicable
REDUCING EARLY MORTALITY AND EARLY MORBIDITY BY EMPIRIC TUBERCULOSIS TREATMENT REGIMENS (REMEMBER)
PER-098-11INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS,20
Unknown
Phase 4
Empiric Tuberculosis (TB) Treatment reduces Early Mortality and MorbidityHealth Condition 1: null- HIV Infection
CTRI/2012/11/003088AIDS Clinical Trials Group National Institute of Allergy and Infectious Diseases NIAID USA836
Terminated
Not Applicable
Evaluation of mortality and morbidity outcome in patients with septic shock due to intra-abdominal sepsis using Alteco Lipopolysaccharide adsorption technique
ACTRN12610000892011Department of intensive care, Pamela Youde Nethersole Eastern Hospital20
Active, not recruiting
Not Applicable
Online feasibility trial for early intervention in eating disorders to improve help seeking behaviours
ISRCTN15662055King's College London176